Infection prevention and control guideline for cystic fibrosis: 2013 update. - Wikidata - awgldk - TriplyDB

Infection prevention and control guideline for cystic fibrosis: 2013 update.

Infection prevention and control guideline for cystic fibrosis: 2013 update.

http://www.wikidata.org/entity/Q42206103

about

Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis Paediatrics: messages from Munich Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices.Chlorhexidine decontamination of sputum for culturing Mycobacterium tuberculosis.Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.Yoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study.Cleaning and infection control of airway clearance devices used by CF patients.Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study The problems of antibiotic resistance in cystic fibrosis and solutions.Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study.Clinical care of children with primary ciliary dyskinesia.Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.Cystic Fibrosis: Microbiology and Host Response Maintaining mental health and function for the long run in cystic fibrosis.The diagnosis and management of respiratory viral infections in cystic fibrosis.Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.Population Dynamics of Staphylococcus aureus in Cystic Fibrosis Patients To Determine Transmission Events by Use of Whole-Genome Sequencing.Use of Selective Fungal Culture Media Increases Rates of Detection of Fungi in the Respiratory Tract of Cystic Fibrosis Patients.A description of clinician reported diagnosis of type 2 diabetes and other non-type 1 diabetes included in a large international multicentered pediatric diabetes registry (SWEET).Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology.Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.Development and Validation of a PCR Assay To Detect the Prairie Epidemic Strain of Pseudomonas aeruginosa from Patients with Cystic Fibrosis.Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.Seeing is Engaging: Vlogs as a Tool for Patient Engagement.Biomarkers of inflammation in infants with cystic fibrosis.New opportunities for managing acute and chronic lung infections.Surgical masks reduce airborne spread of Pseudomonas aeruginosa in colonized patients with cystic fibrosis.Nontuberculous Mycobacteria in Cystic Fibrosis.Linezolid-Resistant Staphylococcus aureus in Children With Cystic Fibrosis.Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.Risk factor analysis and management strategies of operating room-related infections after coronary artery bypass grafting Effects of high intensity interval training on exercise capacity in people with cystic fibrosis: study protocol for a randomised controlled trial

P2860

Q28066704-46CF00B1-C5A3-49B8-A146-43A956436F10 Q28551306-47F30EDF-BFFD-4BA3-A19A-76111AD51580 Q28596759-01FBBFD9-6AE8-411A-BD03-3566E16A04DE Q30388877-0C4484EC-B2B3-4DCB-A6B3-6D552883E7B7 Q33755342-FCCAB513-5365-4EA2-97A1-FB69DC1B6003 Q34425638-AB73AE63-7FA1-424B-9762-A4FF37540211 Q34998656-2EF38847-0134-4715-B065-739A747ADA5F Q35736028-61A4642B-3B58-4ADC-A8B0-722DECE1229C Q35834075-198452E6-6FC2-4810-A5CD-D6B0BD2A70B7 Q36216240-ACEBCE51-18E8-4A19-8790-AACA9196832F Q36301011-0E03499C-8167-4C0E-8B2A-F9CAD45B5809 Q36373818-426AE7E3-CF0B-4AF6-88DA-59E63010B261 Q36824415-65D18470-1FC6-4E20-81D0-BAB2063B14C0 Q37481693-F7207B85-2088-4235-9670-A8D1793AC55E Q37576913-11EFAA15-D57F-483B-81C9-C86388930438 Q38300820-757906DC-E3BA-41A8-8CB1-C3AAE2FDD863 Q38386414-84F785C4-15F5-4E6F-9D44-AB6FB73A4F0A Q38660482-EEA96382-78EF-4BFB-851D-77BF46B0C21D Q38863609-44C7A43E-80BC-482F-9666-36FFEEAC9BDA Q38911644-AA09A2BE-F89A-4CBD-BF03-CE19BD4F851A Q38962750-3F405DFA-CDB3-458F-BDF3-B57C92C37704 Q39108263-1E4DE0CA-849A-4FDE-AEC5-AD2B6DF813B8 Q40054770-9B3A5CFD-F29F-416E-B5C5-068C7BCE91D0 Q40105904-A8B58E7A-511D-4659-839A-1B9FC081857A Q40236173-AEDB0CFF-9841-4FEC-9EEC-1FA8CCD4DE3F Q40366526-07CF0CF0-9BBF-45BD-BE57-AB2A49BB4167 Q40539071-1FCFCF90-A205-46A5-8783-4B1175352BA9 Q40675257-ECBCB36E-3529-4154-AEFA-0A7E3E745B4B Q40704655-CC1BD99F-4F5D-4E5D-B100-7D67B180C9C0 Q40874185-BD6879C3-40CD-4096-B998-D71C2C051994 Q43538692-CD7F1375-5F40-4D5C-8287-53B394FDA79C Q46141297-D75C335F-C4FD-4705-AE79-CA3AA95FC6BE Q47196264-87E8F242-14AB-46C6-A077-927F82B3F0B3 Q47734944-F88E0E26-2E5F-402E-81CE-2A057511760A Q51700716-7A1A80EB-737E-48E6-ADE7-48758283B517 Q52768051-3A977B0C-E10F-4C5E-AE5F-2A92525350DE Q53811912-2936F619-9D55-4D58-93D7-74ADC8CF0F47 Q54205022-E55ABA99-DC68-4CA0-AEEC-DAA32C96FFCA Q58804406-0867D30A-BAC5-4AD2-8863-AA5163FF619C Q59137531-36545720-EB1D-404D-8D39-0ADE3C74EF6A

P2860

Infection prevention and control guideline for cystic fibrosis: 2013 update.

http://www.wikidata.org/entity/Q42206103

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Infection prevention and control guideline for cystic fibrosis: 2013 update.

@en

Infection prevention and control guideline for cystic fibrosis: 2013 update.

@nl

type

label

Infection prevention and control guideline for cystic fibrosis: 2013 update.

@en

Infection prevention and control guideline for cystic fibrosis: 2013 update.

@nl

prefLabel

Infection prevention and control guideline for cystic fibrosis: 2013 update.

@en

Infection prevention and control guideline for cystic fibrosis: 2013 update.

@nl

P1433

Q42206103-7D1AA8E2-C64F-4FE5-B504-9321A55D26AF

P1476

Q42206103-FC155CE3-26E4-4A17-8095-E9550734F74A

P2093

Q42206103-17354778-9A7B-41FC-A990-03EC2894679E

Q42206103-1AA7E470-DDEC-40A9-8F57-141F5E5AF0FD

Q42206103-22A8ECE9-02FF-4745-886A-FDBD64235F33

Q42206103-34759791-6105-4C1A-A181-989F67D8CCF8

Q42206103-39CFE443-CE5B-4453-BB7B-D6097C703E92

Q42206103-462057A5-7FCA-4E85-A3CE-E47A5ACE618C

Q42206103-4A4CF1EB-7D40-41C5-AA87-50AFC9AC19E3

Q42206103-4A5FCA42-46F9-4B7B-AE02-2C8976F75391

Q42206103-4BF25488-B333-4425-BE72-F300D56C71B2

Q42206103-522ACEE2-2FB5-45C1-A305-AE0C3AF8053E

P2860

Q42206103-012B922D-5BF3-4D64-A37D-AD28B6914905

Q42206103-041C9AF4-E85B-4652-B79F-01C02097C647

Q42206103-05EFBB7A-285B-4991-ADC7-7E7DCCAC53E8

Q42206103-06A20ADB-C175-476B-ABCA-AC1900A8421B

Q42206103-0724FCA1-4080-47A4-BC41-A61A3D0F215F

Q42206103-072722D1-B4A7-4350-8928-77CA73DC8197

Q42206103-0745A558-57AF-4806-B3E6-B4F73BFC3526

Q42206103-08DB61B1-8AE5-45AC-BB48-9E145C99F8B6

Q42206103-09778F83-2F4A-4534-87C9-DEDA7E4454A9

Q42206103-0A9A7C17-7A7F-42C7-88D1-53DD35AFA49A

P304

Q42206103-6D1A5402-6711-4E71-BBDB-D13542F1518C

P31

Q42206103-40BC30A2-DDF4-4260-BA11-4D6D4980B20A

P356

Q42206103-8BB03EAD-82FE-4DE3-9A7A-D24ACB413DFC

P478

Q42206103-E1FD4B42-9127-4A8D-9D74-5F6E64576701

P50

Q42206103-69B13E87-14C7-4B37-8E81-6F2BF89D209C

P577

Q42206103-A5144E50-1E0C-4060-9351-4A3A77DB4E18

P5875

Q42206103-90982903-D842-4F37-BC1A-1C220A7AC9B2

P698

Q42206103-F2EEB7A8-CFF7-4FE7-BAE9-9FF1CDAC8335

P921

Q42206103-7409E3A8-6006-49C5-8B18-5B3A2BD8BD65

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Infection prevention and control guideline for cystic fibrosis: 2013 update.

@en

P2093

Bruce C Marshall

http://www.w3.org/2001/XMLSchema#string

Catherine O'Malley

http://www.w3.org/2001/XMLSchema#string

Cystic Fibrous Foundation

http://www.w3.org/2001/XMLSchema#string

David J Weber

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Bryson

http://www.w3.org/2001/XMLSchema#string

Elizabeth Tullis

http://www.w3.org/2001/XMLSchema#string

Gail Potter-Bynoe

http://www.w3.org/2001/XMLSchema#string

H Joel Schmidt

http://www.w3.org/2001/XMLSchema#string

Jane D Siegel

http://www.w3.org/2001/XMLSchema#string

Jennifer Webber

http://www.w3.org/2001/XMLSchema#string

P2860

The changing epidemiology of Staphylococcus aureus?

Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak

Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy

Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Staphylococcus aureus infections

Genomic diversity of the genus Stenotrophomonas

Consumer antibacterial soaps: effective or just risky?

Pulmonary aspergillosis: a clinical review

Vaccines and immunotherapy against Pseudomonas aeruginosa

P304

S1-S67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/676882

http://www.w3.org/2001/XMLSchema#string

P478

35 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Society for Healthcare Epidemiology of America

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263933002

http://www.w3.org/2001/XMLSchema#string

P698

25025126

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis